Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
N4 Pharma Plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $85.0K | $85.0K - $85.0K | $17.0K | -$0.01 | 1 |
| Dec 2027 | $80.0K | $80.0K - $80.0K | $16.0K | -$0.009 | 1 |
| Dec 2026 | $80.0K | $80.0K - $80.0K | $16.0K | -$0.01 | 1 |
| Dec 2025 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.016 | 1 |
| Dec 2024 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.016 | 1 |
| Dec 2021 | $85.0K | $85.0K - $85.0K | $17.0K | -$0.01 | 1 |
| Dec 2020 | $80.0K | $80.0K - $80.0K | $16.0K | -$0.009 | 1 |
| Dec 2018 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.016 | 1 |